1
|
Rojas JJ, Torrisi E, Dubois MAJ, Hossain R, White AJP, Zappia G, Mousseau JJ, Choi C, Bull JA. Oxetan-3-ols as 1,2-bis-Electrophiles in a Brønsted-Acid-Catalyzed Synthesis of 1,4-Dioxanes. Org Lett 2022; 24:2365-2370. [PMID: 35311271 PMCID: PMC9007565 DOI: 10.1021/acs.orglett.2c00568] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
![]()
Annulations
that combine diacceptors with bis-nucleophiles are
uncommon. Here, we report the synthesis of 1,4-dioxanes from 3-aryloxetan-3-ols,
as 1,2-bis-electrophiles and 1,2-diols. Brønsted acid Tf2NH catalyzes both the selective activation of the oxetanol,
to form an oxetane carbocation that reacts with the diol, and intramolecular
ring opening of the oxetane. High regio- and diastereoselectivity
are achieved with unsymmetrical diols. The substituted dioxanes and
fused bicyclic products present interesting motifs for drug discovery
and can be further functionalized.
Collapse
Affiliation(s)
- Juan J. Rojas
- Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, White City Campus, Wood Lane, London W12 0BZ, U.K
| | - Elena Torrisi
- Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, White City Campus, Wood Lane, London W12 0BZ, U.K
- Department of Biomolecular Sciences, School of Pharmacy, University of Urbino “Carlo Bo”, P.za Rinascimento, 6, 61029 Urbino (PU), Italy
| | - Maryne A. J. Dubois
- Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, White City Campus, Wood Lane, London W12 0BZ, U.K
| | - Riashat Hossain
- Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, White City Campus, Wood Lane, London W12 0BZ, U.K
| | - Andrew J. P. White
- Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, White City Campus, Wood Lane, London W12 0BZ, U.K
| | - Giovanni Zappia
- Department of Biomolecular Sciences, School of Pharmacy, University of Urbino “Carlo Bo”, P.za Rinascimento, 6, 61029 Urbino (PU), Italy
| | - James J. Mousseau
- Pfizer Worldwide Research, Development and Medical, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Chulho Choi
- Pfizer Worldwide Research, Development and Medical, Eastern Point Road, Groton, Connecticut 06340, United States
| | - James A. Bull
- Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, White City Campus, Wood Lane, London W12 0BZ, U.K
| |
Collapse
|
2
|
Robert‐Scott G, St‐Gelais J, Giguère D. Annulative Dimerization of Carbohydrates: Synthesis of Complex
C
2
‐Symmetrical 1,4‐Dioxane‐Sugar Hybrids. European J Org Chem 2021. [DOI: 10.1002/ejoc.202100411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Gabrielle Robert‐Scott
- Département de Chimie Université Laval 1045 av. De la Médecine Québec City, Qc G1V 0A6 Canada
| | - Jacob St‐Gelais
- Département de Chimie Université Laval 1045 av. De la Médecine Québec City, Qc G1V 0A6 Canada
| | - Denis Giguère
- Département de Chimie Université Laval 1045 av. De la Médecine Québec City, Qc G1V 0A6 Canada
| |
Collapse
|
3
|
Li M, Huang C, Wu X, Ding F, Hu Z, Zhu Y, Zhao L, Hou L, Chen H, Wang H, Xu J, Tang D. The optimization of a novel selective antagonist for human M 2 muscarinic acetylcholine receptor. Bioorg Med Chem Lett 2020; 30:127632. [PMID: 33132116 DOI: 10.1016/j.bmcl.2020.127632] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Revised: 10/14/2020] [Accepted: 10/16/2020] [Indexed: 01/22/2023]
Abstract
Muscarinic acetylcholine receptors (mAChRs) comprise five distinct subtypes denoted M1 to M5. The antagonism of M2 subtype could increase the release of acetylcholine from vesicles into the synaptic cleft and improve postsynaptic functions in the hippocampus via M1 receptor activation, displaying therapeutic potentials for Alzheimer's disease. However, drug development for M2 antagonists is still challenged among different receptor subtypes. In this study, by optimizing a scaffold from virtual screening, we synthesized two focused libraries and generated up to 50 derivatives. By measuring potency and binding selectivity, we discovered a novel M2 antagonist, ligand 47, featuring submicromolar IC50, high M2/M4 selectivity (~30-fold) and suitable lipophilicity (cLogP = 4.55). Further study with these compounds also illustrates the structure-activity relationship of this novel scaffold. Our study could not only provide novel lead structure, which was easy to synthesize, but also offer valuable information for further development of selective M2 ligands.
Collapse
Affiliation(s)
- Miaomiao Li
- Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| | - Chen Huang
- Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pu Jian Road, Shanghai 200127, China; College of Medical Imaging, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China
| | - Xingyu Wu
- College of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China
| | - Fan Ding
- Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pu Jian Road, Shanghai 200127, China
| | - Zhoumi Hu
- Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pu Jian Road, Shanghai 200127, China
| | - Yan Zhu
- School of Medical Instrument and Food Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China
| | - Lanxue Zhao
- Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| | - Lina Hou
- Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| | - Hongzhuan Chen
- Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Institute of Interdisciplinary Integrative Biomedical Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
| | - Hao Wang
- Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| | - Jianrong Xu
- Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
| | - Dewei Tang
- Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pu Jian Road, Shanghai 200127, China.
| |
Collapse
|
4
|
Del Bello F, Bonifazi A, Giorgioni G, Quaglia W, Amantini C, Morelli MB, Santoni G, Battiti FO, Vistoli G, Cilia A, Piergentili A. Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells. Eur J Med Chem 2019; 168:461-473. [DOI: 10.1016/j.ejmech.2019.02.056] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2018] [Revised: 02/15/2019] [Accepted: 02/18/2019] [Indexed: 12/24/2022]
|
5
|
Morelli MB, Amantini C, Santoni G, Pellei M, Santini C, Cimarelli C, Marcantoni E, Petrini M, Del Bello F, Giorgioni G, Piergentili A, Quaglia W. Novel antitumor copper( ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity. NEW J CHEM 2018. [DOI: 10.1039/c8nj01763h] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
An NMDA receptor ligand was linked to bifunctionalizable species to form copper(ii) complexes, showing antitumor activity through synergistic action mechanisms.
Collapse
|
6
|
Del Bello F, Bonifazi A, Giorgioni G, Petrelli R, Quaglia W, Altomare A, Falcicchio A, Matucci R, Vistoli G, Piergentili A. Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments. Eur J Med Chem 2017; 137:327-337. [DOI: 10.1016/j.ejmech.2017.06.004] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2017] [Revised: 05/24/2017] [Accepted: 06/02/2017] [Indexed: 12/18/2022]
|
7
|
Bonifazi A, Del Bello F, Mammoli V, Piergentili A, Petrelli R, Cimarelli C, Pellei M, Schepmann D, Wünsch B, Barocelli E, Bertoni S, Flammini L, Amantini C, Nabissi M, Santoni G, Vistoli G, Quaglia W. Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring. J Med Chem 2015; 58:8601-15. [PMID: 26430967 DOI: 10.1021/acs.jmedchem.5b01214] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Two series of 1,4-dioxanes (4-11 and 12-19) were rationally designed and prepared to interact either with the phencyclidine (PCP) binding site of the N-methyl-d-aspartate (NMDA) receptor or with σ1 receptors, respectively. The biological profiles of the novel compounds were assessed using radioligand binding assays, and the compounds with the highest affinities were investigated for their functional activity. The results were in line with the available pharmacophore models and highlighted that the 1,4-dioxane scaffold is compatible with potent antagonist activity at NMDA receptor or high affinity for σ1 receptors. The primary amines 6b and 7 bearing a cyclohexyl and a phenyl ring or two phenyl rings in position 6, respectively, were the most potent noncompetitive antagonists at the NMDA receptor with IC50 values similar to those of the dissociative anesthetic (S)-(+)-ketamine. The 5,5-diphenyl substitution associated with a benzylaminomethyl moiety in position 2, as in 18, favored the interaction with σ1 receptors.
Collapse
Affiliation(s)
- Alessandro Bonifazi
- Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino , Via S. Agostino 1, 62032 Camerino, Italy
- Institut für Pharmazeutische und Medizinische Chemie, Universität Münster , Corrensstraße 48, 48149 Münster, Germany
| | - Fabio Del Bello
- Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino , Via S. Agostino 1, 62032 Camerino, Italy
| | - Valerio Mammoli
- Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino , Via S. Agostino 1, 62032 Camerino, Italy
| | - Alessandro Piergentili
- Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino , Via S. Agostino 1, 62032 Camerino, Italy
| | - Riccardo Petrelli
- Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino , Via S. Agostino 1, 62032 Camerino, Italy
| | - Cristina Cimarelli
- Scuola di Scienze e Tecnologie, Università di Camerino , Via S. Agostino 1, 62032 Camerino, Italy
| | - Maura Pellei
- Scuola di Scienze e Tecnologie, Università di Camerino , Via S. Agostino 1, 62032 Camerino, Italy
| | - Dirk Schepmann
- Institut für Pharmazeutische und Medizinische Chemie, Universität Münster , Corrensstraße 48, 48149 Münster, Germany
| | - Bernhard Wünsch
- Institut für Pharmazeutische und Medizinische Chemie, Universität Münster , Corrensstraße 48, 48149 Münster, Germany
| | - Elisabetta Barocelli
- Dipartimento di Farmacia, Università degli Studi di Parma , V.le delle Scienze 27/A, 43124 Parma, Italy
| | - Simona Bertoni
- Dipartimento di Farmacia, Università degli Studi di Parma , V.le delle Scienze 27/A, 43124 Parma, Italy
| | - Lisa Flammini
- Dipartimento di Farmacia, Università degli Studi di Parma , V.le delle Scienze 27/A, 43124 Parma, Italy
| | - Consuelo Amantini
- Scuola di Bioscienze e Medicina Veterinaria, Università di Camerino , via Madonna delle Carceri 9, 62032 Camerino, Italy
| | - Massimo Nabissi
- Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino , Via Madonna delle Carceri 9, 62032 Camerino, Italy
| | - Giorgio Santoni
- Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino , Via Madonna delle Carceri 9, 62032 Camerino, Italy
| | - Giulio Vistoli
- Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano , Via Mangiagalli 25, 20133 Milano, Italy
| | - Wilma Quaglia
- Scuola di Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino , Via S. Agostino 1, 62032 Camerino, Italy
| |
Collapse
|